November 18, 2022

Internal Opportunities

SVPR: The Female Founders Forum at Emory (F3@E)


The Office of the Senior Vice President for Research is launching a new program, The Female Founders Forum (TF3), to support the entrepreneurial development of female faculty at Emory who are launching a startup company to license and develop their invention. To be considered, applicants should already have plans for their startup or have a startup underway. The target technology for the startup should be an Emory-owned technology(s).


Applications Due: 12/9/2022

View RFP

The Halle Institute for Global Research: Global Perspectives on Race+, Ethnicity+, and Nation+


“Global Perspectives on Race+, Ethnicity+, and Nation+” is a new grant offered by the Halle Institute for Global Research. Full-time, continuing, regular faculty from any of Emory’s nine schools are eligible to apply as Primary Investigators for innovative research projects from any disciplinary, interdisciplinary, or multi-disciplinary perspective. Student participation is encouraged but not required.


Applications Open: 11/28/2022

View Program Description

HERCULES Exposome Research Center: Environmental Health Sciences Pilot Grants


The HERCULES Exposome Research Center (NIEHS P30 ES019776) is pleased to announce the 2023-2024 Pilot Project Program in Environmental Health Sciences. HERCULES will fund at least six pilot awards at $30,000 direct costs each. Additional awards are made possible through partnerships with the Winship Cancer Institute and the Emory Children’s Health Assessment, Research Translation, and Combating Environmental Racism (CHARTER) Center.


Letter of Intent Due: 12/5/2022

View RFP

University Research Committee: Albert E. Levy Award for Excellence in Scientific Research


The Albert E. Levy Award for Excellence in Scientific Research was established to recognize the contributions of Emory faculty members to the advancement of scientific knowledge. This award was created by Edith Levy Elsas, a civic and academic activist, while she was a member of the Emory University Board of Visitors in memory of her father, Albert E. Levy. The award is overseen by the University Research Committee (URC).


Nominations Due: 12/9/2022

View RFP

The Halle Institute for Global Research/URC: URC-Halle Institute Global Research Award


The Halle Institute for Global Research has partnered with the University Research Committee (URC) to award up to eight grants in any of the following six URC categories for individual or collaborative research with an international dimension.


Applications Due: 1/17/2023

View RFP

Featured Opportunities

2023 Pilot & Feasibility Project Program


The CDTR is a collaboration of Emory University, Georgia Tech, and Morehouse School of Medicine, with funding provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and interinstitutional sponsors. The mission of the center is to facilitate and grow diabetes translation research at the partner institutions, within Georgia, and regionally with the overarching theme of health equity across race/ethnicity, age, sex and gender identity, geography (rural, urban), and associated comorbid conditions (e.g., cardiovascular disease, HIV, depression, cancer, cystic fibrosis, covid-19 and long-term consequences, and others).


Letter of Intent due by 11/30/22, Applications due by 2/15/2023

View Full Application Guidelines
More information

Annual Request for Proposals


Biolocity provides funding and mentorship to advance innovations that impact human health and are seeking proposals for their current $1.5M funding cycle. Commercialization funding is available for a broad range of technology types including device, drug delivery, therapeutic, and health IT. Applications are by invite only. If selected to move forward, the pre-proposal is due Jan. 3, 2023.


Schedule a technology meeting with the Biolocity team before 12/16/22 to describe your technology, its development stage, and the problem it solves.


Request a Meeting
View Application Guidelines

Applied Research Projects


The Partnership for Inclusive Innovation is looking to support applied research projects that have a meaningful impact on Georgians! Grantees will be expected to work closely with community stakeholders over a period of 12 – 16 months to advance their research, including their proposed scope of work.


Deadline for Applications: Proposal accepted anytime and reviewed twice per year (April and September).

View Guidelines

AI.Humanity

Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)


This Funding Opportunity Announcement (FOA) encourages grant applications to develop and translate medical technologies aimed at reducing disparities in healthcare access and health outcomes. Appropriate medical technologies should be effective, affordable, culturally acceptable, and deliverable to those who need them.


Deadline: 1/26/2023

Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional)


The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of devices to treat Substance Use Disorders (SUDs). The continuing advances in technologies offer unprecedented opportunities to develop neuromodulatory or neurophysiological devices that are safe and effective SUD treatments. The objective is to move devices to their next step in the FDA approval process, with the ultimate goal of generating new, FDA approved device-based treatments for SUDs.

Deadline: 12/14/2022

Infectious Diseases

Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)


This Funding Opportunity Announcement (FOA) seeks innovative research to optimize HIV prevention and care which is aligned with NIMH Division of AIDS Research (DAR) priorities. Applications may include formative basic behavioral and social science to better understand a step or steps in the HIV prevention or care continuum, and/or the initial development and pilot testing of innovative intervention approaches. Applicants are encouraged to read current Notices of Special Interests (NOSIs) from NIMH DAR for further information about the Division’s research priorities.


AIDS Deadline: 1/7/2023

Molecular Dynamics of HIV (R01 Clinical Trial Not Allowed)


The purpose of this Funding Opportunity Announcement (FOA) is to support computational dynamic modeling of molecular complexes regulating the HIV life cycle, immune responses, and therapeutic interventions in HIV/AIDS using existing and new HIV and HIV/host cell structural datasets.


AIDS Deadline: 12/7/2022

Brain Health

Neurobiology of Brain Disorders Award


The McKnight Neurobiology of Brain Disorders Award (NBD Award) assists scientists working to apply the knowledge achieved through basic research to human brain disorders, and who demonstrate a commitment to equitable and inclusive lab environments.


Letter of Intent: 12/12/2022

Please contact your RAS unit *and* Duke Guthrie to inform them of your intent to submit.

Utilizing Telomere Status to Reveal Molecular Mechanisms Underlying Susceptibility and Resiliency in Response to Environmental Exposures (R01 Clinical Trial Not Allowed)


The purpose of this funding opportunity announcement (FOA) is to solicit applications that further examine and characterize molecular underpinnings surrounding telomere status and accompanying biological pathways in response to environmental insults. Specifically, the intent is to further stimulate the field on how general telomere maintenance modulates downstream biological pathway(s) leading to cellular and organismal dysfunction. It is anticipated that proposed studies examining exposure affects at telomeric regions can actually potentiate early onset of age-related diseases.


Deadline: 2/14/2023

Cancer

Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)


This Funding Opportunity Announcement (FOA) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology in the context of a testable cancer research hypothesis. The projects supported by this FOA will collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program.


Deadline: 2/5/2023

Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed)


This Funding Opportunity Announcement (FOA) solicits grant applications proposing to utilize bacteria, archaebacteria, bacteriophages, or other non-oncolytic viruses and their natural products to study the underlying mechanisms of the complex interactions between microorganisms, tumors, and the immune system, and to explore their clinical potential for cancer imaging, therapeutics or diagnostics. Projects can focus on using microorganisms as anti-tumor agents, as activators of anti-tumor immunity, or as delivery vehicles for treatment, diagnosis, or imaging, complementing or synergizing with existing tools and approaches. This FOA will support basic mechanistic and preclinical studies in cell culture and animal models. Applicants are encouraged to address both the microbial and tumor aspects of microbial tumor interactions relevant to microbial-based cancer therapy (including therapies for oral cancer), tumor imaging, tumor detection, or diagnosis.


Deadline: 2/16/2023

Global Health

Center for Early Lifestage Vulnerabilities to Environmental Stressors - Cumulative Health Impacts for Children in Underserved Rural Agricultural Communities in the United States


Protecting children’s health is one of the most important responsibilities of the U.S. Environmental Protection Agency (EPA). "It is the U.S. Environmental Protection Agency's policy to protect children from environmental exposures by consistently and explicitly considering early life exposures and lifelong health in all human health decisions. Children's environmental health refers to the effect of environmental exposure during early life: from conception, infancy, early childhood and through adolescence until 21 years of age. The EPA' s policy is informed by the scientific understanding that children may be at greater risk to environmental contaminants than adults due to differences in behavior and biology and that the effects of early life exposures may also arise in adulthood or in later generations (1).”


Deadline: 1/11/2023

Developing and Demonstrating Nanosensor Technology to Detect, Monitor, and Degrade Pollutants Request for Applications (RFA)


Environmental pollutants such as pesticides, insecticides, dyes, phenols, endocrine disrupters, polycyclic aromatic hydrocarbons, per- and polyfluoroalkyl substances (PFAS), heavy metals, and nitrogen compounds can have adverse effects on human health even at low concentrations. Efforts are consistently being made to develop reliable and simple sensors to detect pollutants even at low levels. Environmental remediation technologies cover a vast range of applications that require tailored engineering solutions for successful implementation. Technologies applied for the treatment of water, soil, or air involve contaminant degradation or sequestration, and often use related processes such as adsorption or reduction/oxidation (redox) reactions.


Deadline: 12/7/2022

Social Justice / DEI

Innovation Award: COVID-19 and Health Equity (U01) Clinical Trials Not Allowed


The purpose of this funding opportunity announcement (FOA) is to fund COVID research that will strengthen and advance research in minority health and healthy equity, increase understanding of health disparities, and provide future direction for research that will contribute to regulatory decision making.


Deadline: 1/16/2023

Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)


This funding opportunity seeks to support the Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) Program. The CPACHE Program develops and maintains comprehensive, long-term, and mutually beneficial partnerships between institutions serving underserved health disparity populations and underrepresented students (ISUPSs) and NCI-designated Cancer Centers (CCs). The program aims to achieve a stronger national cancer program and address challenges in cancer and cancer disparities research, education, and outreach, as well as cancer's impact on underserved populations.


Deadline: 1/6/2023

University Research Committee

URC 2022-23 Call for Proposals - now open!


The University Research Committee (URC) announces the annual Call for Proposals for funding to be used during 2023-2024 in the following categories:

 

  • URC Regular Award
  • URC Interdisciplinary Award
  • URC-Halle Institute Global Research Award (For those conducting research primarily outside of the United States)


All regular, full-time Emory faculty, of all ranks, are welcome to apply. URC eligibility follows criteria for “full-time faculty” as defined within each school. Postdocs, Fellows, Adjuncts, Research Track lines in some schools, and part-time faculty are not eligible.


Please see the full RFP document below for more information.


Deadline: January 17, 2023

View RFP
Finding Funding

Funding Opportunities Calendar 

A comprehensive archive of past, present, and upcoming opportunities can be found on the SVPR funding calendar. Click the link below to view.


SVPR Funding Calendar

Limited and Internal Competitions through InfoReady

Universities involved in research often need to run competitions for grant funding, whether for internal grant dollars or limited submission opportunities through external sponsors.


If you are interested in submitting a proposal to a funding opportunity with an institutional limitation, please check InfoReady to see if it is listed first. If it is not there, please email limited-opps@emory.edu and include the funding opportunity number, title, and due date.




Link to InfoReady

Search Tool for Corporate and Foundation Funding Opportunities

The Office of Corporate Relations and the Office of Foundation Relations have teamed up to create this resource site to provide a curated list of current funding opportunities and other resources. This site will help promote connections between Emory colleagues and corporate/foundation partners.


Link to SharePoint Search Tool

GrantForward

Free access available with Emory Email address. Formally IRIS. Provides access to the University Community to conduct funding searches. The database is provides funding opportunities for the physical and life sciences, social sciences, arts, and humanities.


Link for More Information

Grants.gov

Grants.gov is a central storehouse for information on over 1,000 grant programs from over 27 federal agencies. Interested applicants can search for relevant funding opportunities by Keyword or Category or browse opportunities by agency. The portal is also a central source to apply for federal grants. Information on the processes for proposal submission through Grants.gov can be found in Proposal Submission.

Foundation Directory

Free access available through Databases@Emory. This database, produced by the nation's leading authority on philanthropy, includes extensive program details for thousands of leading foundations; detailed application guidelines for more than 7,000 grants; and a searchable file of approximately half a million grants.

Link for More Information

Visit our website
Twitter  
Subscribe